Trial Profile
Effects of Montelukast on Occult Exercise-Induced Bronchospasm in Athletes
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 06 May 2022
Price :
$35
*
At a glance
- Drugs Montelukast (Primary)
- Indications Bronchospasm
- Focus Therapeutic Use
- Acronyms EMOEBA
- 06 Jan 2016 Status changed from not yet recruiting to withdrawn prior to enrolment, as reported by ClinicalTrials.gov record.
- 16 Dec 2006 New trial record.